Table 5.
Serotype 4 N = 98 |
Serotype 6B N = 100 |
Serotype 14 N = 100 |
Serotype 23F N = 100 |
|
---|---|---|---|---|
≥ 2-fold increase in pneumococcal IgG and functional OI | 46 (47) | 57 (57) | 32 (32) | 56 (56) |
≥ 2-fold increase in pneumococcal IgG, but not functional OI | 4 (4) | 6 (6) | 8 (8) | 3 (3) |
≥ 2-fold increase in functional OI, but not pneumococcal IgG | 28 (29) | 19 (19) | 15 (15) | 17 (17) |
< 2-fold increase in both pneumococcal IgG and functional OI | 20 (20) | 18 (18) | 45 (45) | 24 (24) |
Data are reported as n (%)
IgG immunoglobulin G, OI opsonization index, PCV-13 13-serotype pneumococcal conjugate vaccine